Cell Cotransplantation Strategies for Vascularized Craniofacial Bone Tissue Engineering : A Systematic Review and Meta-Analysis of Preclinical In Vivo Studies

DSpace Repository

Cell Cotransplantation Strategies for Vascularized Craniofacial Bone Tissue Engineering : A Systematic Review and Meta-Analysis of Preclinical In Vivo Studies

Details

Files for download

Find Full text There are no files associated with this item..

Overview of item record
Publication Article, review peer-reviewed scientific
Title Cell Cotransplantation Strategies for Vascularized Craniofacial Bone Tissue Engineering : A Systematic Review and Meta-Analysis of Preclinical In Vivo Studies
Author Shanbhag, Siddharth ; Pandis, Nikolaos ; Mustafa, Kamal ; Nyengaard, Jens R. ; Stavropoulos, Andreas
Date 2017
English abstract
The regenerative potential of tissue-engineered bone constructs may be enhanced by in vitro coculture and in vivo cotransplantation of vasculogenic and osteogenic (progenitor) cells. The objective of this study was to systematically review the literature to answer the focused question: In animal models, does cotransplantation of osteogenic and vasculogenic cells enhance bone regeneration in craniofacial defects, compared with solely osteogenic cell-seeded constructs? Following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, electronic databases were searched for controlled animal studies reporting cotransplantation of endothelial cells (ECs) with mesenchymal stem cells (MSCs) or osteoblasts in craniofacial critical size defect (CSD) models. Twenty-two studies were included comparing outcomes of MSC/scaffold versus MSC+ EC/scaffold (co)transplantation in calvarial (n = 15) or alveolar (n = 7) CSDs of small (rodents, rabbits) and large animal (minipigs, dogs) models. On average, studies presented with an unclear to high risk of bias. MSCs were derived from autologous, allogeneic, xenogeneic, or human (bone marrow, adipose tissue, periosteum) sources; in six studies, ECs were derived from MSCs by endothelial differentiation. In most studies, MSCs and ECs were cocultured in vitro (2-17 days) before implantation. Coculture enhanced MSC osteogenic differentiation and an optimal MSC: EC seeding ratio of 1: 1 was identified. Alloplastic copolymer or composite scaffolds were most often used for in vivo implantation. Random effects meta-analyses were performed for histomorphometric and radiographic new bone formation (% NBF) and vessel formation in rodents' calvarial CSDs. A statistically significant benefit in favor of cotransplantation versus MSC-only transplantation for radiographic % NBF was observed in rat calvarial CSDs (weighted mean difference 7.80% [95% confidence interval: 1.39-14.21]); results for histomorphometric % NBF and vessel formation were inconclusive. Overall, heterogeneity in the meta-analyses was high (I-2 > 80%). In summary, craniofacial bone regeneration is enhanced by cotransplantation of vasculogenic and osteogenic cells. Although the direction of treatment outcome is in favor of cotransplantation strategies, the magnitude of treatment effect does not seem to be of relevance, unless proven otherwise in clinical studies.
DOI https://doi.org/10.1089/ten.teb.2016.0283 (link to publisher's fulltext.)
Publisher Mary Ann Liebert
Host/Issue Tissue Engineering - Part B: Reviews;2
Volume 23
ISSN 1937-3368
Language eng (iso)
Subject bone tissue engineering
coculture
endothelial cells
mesenchymal stem cells
meta-analysis
vascularization
Sciences
Research Subject Categories::NATURAL SCIENCES
Handle http://hdl.handle.net/2043/23588 Permalink to this page
Facebook

This item appears in the following Collection(s)

Details

Search


Browse

My Account

Statistics